Pharma Co. Slams Patent Challenge Standing In Fed. Circ.
Pharmaceuticals company Bristol-Myers Squibb Co. asked the Federal Circuit Tuesday to reject for lack of standing a competitor's appeal of a U.S. Patent Trial and Appeal Board decision upholding its patent...To view the full article, register now.
Already a subscriber? Click here to view full article